Petros Pharmaceuticals, Inc. (PTPI)

$0.29 -7.72% $-0.02 Healthcare

Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease. The company markets its line of ED products in the form of vacuum erection device products. Petros Pharmaceuticals, Inc. is based in New York, New York.

$2.87M

Mr. John D. Shulman

24.00

New York, NY

Dec 02, 2020

-0.05

$-6.25

0.93

1.65

-6,229.97%

-0.01

0.22

0.72

1.25

-835.45%

-1,459.20%

Similar stocks (6)

Alimera Sciences, Inc.

ALIM

$5.54 -0.18%
Neutral

Lifecore Biomedical, Inc.

LFCR

$6.86 4.89%
Neutral

Cumberland Pharmaceuticals Inc.

CPIX

$1.20 0.00%
Downtrend

Agile Therapeutics, Inc.

AGRX

$1.51 3.42%
Uptrend

Evoke Pharma, Inc.

EVOK

$5.00 -7.06%
Downtrend

Guardion Health Sciences, Inc.

GHSI

$3.22 -2.13%
Downtrend